Correlating and combing intra- and inter-metastases radiophenotypic heterogeneity and molecular heterogeneity according to circulating tumor DNA to improve prognosis prediction and response under systemic treatment in patients with metastatic solid cancers.
More information on the link on the right
Institut Bergonié, Bordeaux, France